Valeo Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,100
Closed -$287K 702
2024
Q4
$287K Buy
+1,100
New +$326K 0.01% 554

Other funds holding AMGN

Valeo Financial Advisors's AMGN Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Amgen (AMGN) stake by 7.3% in Q2 2026, selling an estimated $470K and leaving 17,375 shares worth $6.29M. The position accounts for 0.13% of the portfolio, ranked #78.

Valeo Financial Advisors first reported a position in AMGN in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.98M in Q4 2023. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Valeo Financial Advisors held 17,375 shares of Amgen worth $6.29M as of Q2 2026.
  • Valeo Financial Advisors sold 1,372 Amgen shares in Q2 2026, an estimated $470K.
  • Amgen made up 0.13% of Valeo Financial Advisors's portfolio in Q2 2026, its #78 holding.
  • Valeo Financial Advisors first reported a position in Amgen in Q3 2017 and has held it in 36 quarters since.
  • Valeo Financial Advisors's Amgen position peaked at $6.98M in Q4 2023.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.